Think you might have this condition?
Use the Symptom Checker to check your symptoms
Vertebrobasilar insufficiency
Also known as Vertebral Basilar Insufficiency, Vertebrobasilar Artery Syndrome, and Vertebrobasilar Ischemia
Vertebrobasilar insufficiency (VBI), or vertebral basilar ischemia (also called Beauty parlour syndrome (BPS)), refers to a temporary set of symptoms due to decreased blood flow in the posterior circulation of the brain. The posterior circulation supplies blood to the medulla, cerebellum, pons, midbrain, thalamus, and occipital cortex (responsible for vision). Therefore, the symptoms due to VBI vary according to which portions of the brain experience significantly decreased blood flow (see image of brain ). In the United States, 25% of strokes and transient ischemic attacks occur in the vertebrobasilar distribution. These must be separated from strokes arising from the anterior circulation, which involves the carotid arteries.
Source: WikipediaWhat are the symptoms?
Within all the people who go to their doctor with vertebrobasilar insufficiency, 66% report having dizziness, 52% report having problems with movement, and 52% report having weakness. The symptoms that are highly suggestive of vertebrobasilar insufficiency are problems with movement, sweating, and foot or toe weakness, although you may still have vertebrobasilar insufficiency without those symptoms.
What might my doctor prescribe?
Common Tests and Procedures
Patients with vertebrobasilar insufficiency often receive radiographic imaging procedure, complete blood count, electrocardiogram, glucose measurement, x-ray computed tomography, ultrasonography, cardiac enzymes measurement and physical therapy exercises .
Common Medications
The most commonly prescribed drugs for patients with vertebrobasilar insufficiency include clopidogrel (plavix), donepezil (aricept), losartan, valsartan (diovan), ticlopidine, biotin, pentoxifylline, eletriptan (relpax), piroxicam, aspirin / dipyridamole, glyburide / metformin, bumetanide and leuprolide (lupron) .
| Clopidogrel (Plavix) | $151 (28 days) | |
| Donepezil (Aricept) | $210 (28 days) | |
| Losartan | $51 (28 days) | |
| Valsartan (Diovan) | $79 (28 days) | |
| Ticlopidine | $27 (28 days) | |
| Biotin | $2 (28 days) | |
| Pentoxifylline | $18 (28 days) | |
| Eletriptan (Relpax) | $212 (21 days) | |
| Piroxicam | $34 (28 days) | |
| Bumetanide | $11 (28 days) | |
| Leuprolide (Lupron) | $961 (28 days) |
Who is at risk?
Groups of people at highest risk for vertebrobasilar insufficiency include age 75+ years age 60-74 years. On the other hand, age 30-44 years, age 5-14 years, age 1-4 years, and age < 1 years almost never get vertebrobasilar insufficiency.
Age
| < 1 years | 0.0x | |
| 1-4 years | 0.0x | |
| 5-14 years | 0.0x | |
| 15-29 years | 0.2x | |
| 30-44 years | 0.0x | |
| 45-59 years | 1.1x | |
| 60-74 years | 1.6x | |
| 75+ years | 5.5x |
Sex
| Male | 1.0x | |
| Female | 1.0x |
Race/Ethnicity
| Black | 1.0x | |
| Hispanic | 0.7x | |
| White | 1.1x | |
| Other | 0.6x |
Loading...